Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
inflammatory5866 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A05997 | 33045675 | J Trace Elem Med Biol | A pilot study of the effects of chromium picolinate supplementation on serum fetuin-A, metabolic and inflammatory factors in patients with nonalcoholic fatty liver disease: A double-blind, placebo-controlled trial. | 2020 | Details |
| A05998 | 33045403 | Contemp Clin Trials | The European NAFLD Registry: A real-world longitudinal cohort study of nonalcoholic fatty liver disease. | 2020 | Details |
| A06009 | 33038502 | Contemp Clin Trials | A randomised, double-blind, placebo-controlled, multi-centre, dose-range, proof-of-concept, 24-week treatment study of lanifibranor in adult subjects with non-alcoholic steatohepatitis: Design of the NATIVE study. | 2020 | Details |
| A06010 | 33038434 | J Hepatol | Role of CC chemokine receptor 9 in the progression of murine and human non-alcoholic steatohepatitis. | 2020 | Details |
| A06043 | 33031439 | PLoS One | In-hospital mortality is associated with inflammatory response in NAFLD patients admitted for COVID-19. | 2020 | Details |
| A06056 | 33026380 | Food Funct | Gut inflammation exacerbates hepatic injury in C57BL/6J mice via gut-vascular barrier dysfunction with high-fat-incorporated meat protein diets. | 2020 | Details |
| A06080 | 33013934 | Front Immunol | CD4+ T Cells Mediate the Development of Liver Fibrosis in High Fat Diet-Induced NAFLD in Humanized Mice. | 2020 | Details |
| A06105 | 33006712 | Mol Biol Rep | Low-dose trans-resveratrol induce poly(ADP)-ribosylation-dependent increase of the PPAR-γ protein expression level in the in vitro model of non-alcoholic fatty liver disease. | 2020 | Details |
| A06113 | 33002003 | PLoS One | REV-ERB agonism improves liver pathology in a mouse model of NASH. | 2020 | Details |
| A06116 | 32999906 | GE Port J Gastroenterol | Gastrointestinal Microbiome - What We Need to Know in Clinical Practice. | 2020 | Details |
| A06122 | 32998095 | Diabetes Metab Syndr | Pathophysiological mechanisms underlying MAFLD. | 2020 | Details |
| A06124 | 32997875 | Mol Nutr Food Res | Characterization of the Nutritional Composition of a Biotechnologically Produced Oyster Mushroom and its Physiological Effects in Obese Zucker Rats. | 2020 | Details |
| A06125 | 32997872 | Mol Nutr Food Res | CREBH: A Complex Array of Regulatory Mechanisms in Nutritional Signaling, Metabolic Inflammation, and Metabolic Disease. | 2020 | Details |
| A06130 | 32994765 | Postepy Dermatol Alergol | Non-alcoholic fatty liver disease in patients with psoriasis: therapeutic implications. | 2019 | Details |
| A06136 | 32992548 | Antioxidants (Basel) | Involvement of HO-1 and Autophagy in the Protective Effect of Magnolol in Hepatic Steatosis-Induced NLRP3 Inflammasome Activation In Vivo and In Vitro. | 2020 | Details |
| A06139 | 32992082 | Phytomedicine | Integrated omics analysis unraveled the microbiome-mediated effects of Yijin-Tang on hepatosteatosis and insulin resistance in obese mouse. | 2020 | Details |
| A06149 | 32987153 | Cell Mol Gastroenterol Hepatol | Tristetraprolin Promotes Hepatic Inflammation and Tumor Initiation but Restrains Cancer Progression to Malignancy. | 2020 | Details |
| A06160 | 32982365 | Clin Exp Gastroenterol | Gut Dysbiosis and Increased Intestinal Permeability Drive microRNAs, NLRP-3 Inflammasome and Liver Fibrosis in a Nutritional Model of Non-Alcoholic Steatohepatitis in Adult Male Sprague Dawley Rats. | 2020 | Details |
| A06166 | 32981113 | Aliment Pharmacol Ther | Digital pathology: accurate technique for quantitative assessment of histological features in metabolic-associated fatty liver disease. | 2020 | Details |
| A06180 | 32978261 | J Biol Chem | ERAD deficiency promotes mitochondrial dysfunction and transcriptional rewiring in human hepatic cells. | 2020 | Details |
| A06195 | 32973925 | Therap Adv Gastroenterol | The role of the gut microbiome and exercise in non-alcoholic fatty liver disease. | 2020 | Details |
| A06197 | 32971870 | Molecules | Urinary Resveratrol Metabolites Output: Differential Associations with Cardiometabolic Markers and Liver Enzymes in House-Dwelling Subjects Featuring Metabolic Syndrome. | 2020 | Details |
| A06205 | 32968123 | Sci Rep | Automated thermal imaging for the detection of fatty liver disease. | 2020 | Details |
| A06213 | 32965553 | Wien Klin Wochenschr | Association between psoriasis, psoriatic arthritis and gastrointestinal disease : An exploratory nationwide inpatient sample analysis. | 2020 | Details |
| A06215 | 32964327 | Int J Cardiovasc Imaging | Correlation between computed tomography adapted leaman score and computed tomography liver and spleen attenuation parameters for non-alcoholic fatty liver disease as well as respective inflammatory mediators. | 2020 | Details |
| A06221 | 32963496 | Mediators Inflamm | Expression of Matrix Metalloproteinases and Their Tissue Inhibitors in Peripheral Blood Leukocytes and Plasma of Children with Nonalcoholic Fatty Liver Disease. | 2020 | Details |
| A06223 | 32963259 | Sci Rep | Mechanistic study of attenuation of monosodium glutamate mixed high lipid diet induced systemic damage in rats by Coccinia grandis. | 2020 | Details |
| A06231 | 32961356 | Cell Mol Gastroenterol Hepatol | Oxidized Low-Density Lipoprotein Drives Dysfunction of the Liver Lymphatic System. | 2020 | Details |
| A06240 | 32956824 | J Nutr Biochem | Combination of metformin and genistein alleviates non-alcoholic fatty liver disease in high-fat diet-fed mice. | 2020 | Details |
| A06246 | 32952876 | World J Hepatol | Glucagon-like peptide-1 receptor agonists in non-alcoholic fatty liver disease: An update. | 2020 | Details |
| A06251 | 32952340 | World J Gastroenterol | Tumor necrosis factor alpha receptor 1 deficiency in hepatocytes does not protect from non-alcoholic steatohepatitis, but attenuates insulin resistance in mice. | 2020 | Details |
| A06254 | 32951749 | Complement Ther Med | Effects of green coffee bean extract on C-reactive protein levels: A systematic review and meta-analysis of randomized controlled trials. | 2020 | Details |
| A06261 | 32948162 | BMC Complement Med Ther | Fermented mulberry (Morus alba) leaves suppress high fat diet-induced hepatic steatosis through amelioration of the inflammatory response and autophagy pathway. | 2020 | Details |
| A06282 | 32942921 | Scand J Rheumatol | Lupus hepatitis, more than just elevated liver enzymes. | 2020 | Details |
| A06285 | 32941865 | Biochem Pharmacol | Aryl hydrocarbon receptor (AHR)-mediated inflammation and resolution: Non-genomic and genomic signaling. | 2020 | Details |
| A06309 | 32933722 | Tissue Cell | Liraglutide in combination with human umbilical cord mesenchymal stem cell could improve liver lesions by modulating TLR4/NF-kB inflammatory pathway and oxidative stress in T2DM/NAFLD rats. | 2020 | Details |
| A06312 | 32932796 | Nutrients | Effects of Omega-3 Polyunsaturated Fatty Acid Supplementation on Non-Alcoholic Fatty Liver: A Systematic Review and Meta-Analysis. | 2020 | Details |
| A06319 | 32930860 | Wien Klin Wochenschr | Open-label phase II study evaluating safety and efficacy of the non-steroidal farnesoid X receptor agonist PX-104 in non-alcoholic fatty liver disease. | 2020 | Details |
| A06322 | 32929325 | Theranostics | Lack of FGF21 promotes NASH-HCC transition via hepatocyte-TLR4-IL-17A signaling. | 2020 | Details |
| A06339 | 32923658 | Cannabis Cannabinoid Res | Cannabis Extracts Affected Metabolic Syndrome Parameters in Mice Fed High-Fat/Cholesterol Diet. | 2020 | Details |
| A06355 | 32918742 | J Pathol | Differential TM4SF5-mediated SIRT1 modulation and metabolic signaling in nonalcoholic steatohepatitis progression. | 2020 | Details |
| A06357 | 32916992 | Molecules | LRRK2 Regulates CPT1A to Promote β-Oxidation in HepG2 Cells. | 2020 | Details |
| A06360 | 32916379 | Nutrition | Pleiotropic ameliorative effects of ellagitannin geraniin against metabolic syndrome induced by high-fat diet in rats. | 2020 | Details |
| A06362 | 32916011 | Liver Transpl | Monoacylglycerol Acyltransferase 1 Knockdown Exacerbates Hepatic Ischemia/Reperfusion Injury in Mice With Hepatic Steatosis. | 2020 | Details |
| A06365 | 32914125 | Curr Res Food Sci | Piceatannol attenuates fat accumulation and oxidative stress in steatosis-induced HepG2 cells. | 2020 | Details |
| A06378 | 32906750 | Int J Mol Sci | The Emerging Relevance of AIM2 in Liver Disease. | 2020 | Details |
| A06383 | 32903892 | Clin Exp Gastroenterol | Prevalence and Risk Factors of Hyperuricemia in Patients with Chronic Kidney Disease and Non-Alcoholic Fatty Liver. | 2020 | Details |
| A06387 | 32899418 | Biomolecules | Hepatic Lipidomics and Molecular Imaging in a Murine Non-Alcoholic Fatty Liver Disease Model: Insights into Molecular Mechanisms. | 2020 | Details |
| A06396 | 32894439 | Dig Dis Sci | Nonalcoholic Fatty Liver Disease Is Common in IBD Patients However Progression to Hepatic Fibrosis by Noninvasive Markers Is Rare. | 2020 | Details |
| A06402 | 32892401 | Scand J Immunol | Macrophages and scavenger receptors in obesity-associated non-alcoholic liver fatty disease (NAFLD). | 2020 | Details |
| A06404 | 32891893 | J Nutr Biochem | Comprehensive characterization of metabolic, inflammatory and fibrotic changes in a mouse model of diet-derived nonalcoholic steatohepatitis. | 2020 | Details |
| A06422 | 32885579 | Liver Int | Association between consumption of edible seaweeds and newly diagnosed non-alcohol fatty liver disease: The TCLSIH Cohort Study. | 2021 | Details |
| A06429 | 32883523 | Biochem Biophys Res Commun | Long-term subcutaneous injection of lipopolysaccharides and high-fat diet induced non-alcoholic fatty liver disease through IKKε/ NF-κB signaling. | 2020 | Details |
| A06432 | 32882583 | Biomed Pharmacother | An update on β-sitosterol: A potential herbal nutraceutical for diabetic management. | 2020 | Details |
| A06442 | 32880077 | Hepatol Int | The role of neutrophils in innate immunity-driven nonalcoholic steatohepatitis: lessons learned and future promise. | 2020 | Details |
| A06450 | 32878147 | Molecules | Potential Anti-Diabetic Activity of Pueraria lobata Flower (Flos Puerariae) Extracts. | 2020 | Details |
| A06451 | 32877694 | Pharmacol Res | Scoparone as a therapeutic drug in liver diseases: Pharmacology, pharmacokinetics and molecular mechanisms of action. | 2020 | Details |
| A06454 | 32877213 | Am J Physiol Gastrointest Liver Physiol | High-fat diet induces fibrosis in mice lacking CYP2A5 and PPARα: a new model for steatohepatitis-associated fibrosis. | 2020 | Details |
| A06457 | 32875543 | J Physiol Biochem | Metabolite profiling of mice under long-term fructose drinking and vitamin D deficiency: increased risks for metabolic syndrome and nonalcoholic fatty liver disease. | 2020 | Details |
| A06471 | 32867260 | Medicina (Kaunas) | Probiotics: Versatile Bioactive Components in Promoting Human Health. | 2020 | Details |
| A06474 | 32865911 | Crit Rev Oncog | Role of the Gut Microbiome in Nonalcoholic Fatty Liver Disease Progression. | 2020 | Details |
| A06478 | 32863955 | Theranostics | Fibrinogen-like protein 2 aggravates nonalcoholic steatohepatitis via interaction with TLR4, eliciting inflammation in macrophages and inducing hepatic lipid metabolism disorder. | 2020 | Details |
| A06480 | 32863329 | Tohoku J Exp Med | Hybrid Training System Improves Insulin Resistance in Patients with Nonalcoholic Fatty Liver Disease: A Randomized Controlled Pilot Study. | 2020 | Details |
| A06484 | 32862405 | Endocrine | PNPLA3 I148M is involved in the variability in anti-NAFLD response to exenatide. | 2020 | Details |
| A06487 | 32859881 | Chin J Physiol | Administration of low-dose resveratrol attenuated hepatic inflammation and lipid accumulation in high cholesterol-fructose diet-induced rat model of nonalcoholic fatty liver disease. | 2020 | Details |
| A06491 | 32856978 | J Med Food | Fisetin Alleviates Hepatic and Adipocyte Fibrosis and Insulin Resistance in Diet-Induced Obese Mice. | 2020 | Details |
| A06502 | 32850884 | Front Med (Lausanne) | Advances in the Involvement of Gut Microbiota in Pathophysiology of NAFLD. | 2020 | Details |
| A06521 | 32841652 | J Allergy Clin Immunol | Regulating metabolic inflammation by nutritional modulation. | 2020 | Details |
| A06538 | 32833043 | Arch Toxicol | A novel model of non-alcoholic steatohepatitis with fibrosis and carcinogenesis in connexin 32 dominant-negative transgenic rats. | 2020 | Details |
| A06547 | 32830817 | J Gastrointestin Liver Dis | Non-alcoholic Steatohepatitis: Comparison of Intestinal Microbiota between Different Metabolic Profiles. A Pilot Study. | 2020 | Details |
| A06555 | 32825982 | J Bodyw Mov Ther | Effects of non-linear resistance training and curcumin supplementation on the liver biochemical markers levels and structure in older women with non-alcoholic fatty liver disease. | 2020 | Details |
| A06563 | 32824349 | Antioxidants (Basel) | Oxidative Stress and Pro-Inflammatory Status in Patients with Non-Alcoholic Fatty Liver Disease. | 2020 | Details |
| A06567 | 32823983 | J Clin Med | Liver Steatosis, Gut-Liver Axis, Microbiome and Environmental Factors. A Never-Ending Bidirectional Cross-Talk. | 2020 | Details |
| A06569 | 32823621 | Nutrients | Effects of Resveratrol Supplementation in Patients with Non-Alcoholic Fatty Liver Disease-A Meta-Analysis. | 2020 | Details |
| A06574 | 32822324 | Orv Hetil | Fat rich diet-induced steatosis and changes in the gut–liver axis | 2020 | Details |
| A06581 | 32821071 | World J Gastroenterol | Helicobacter pylori infection: Beyond gastric manifestations. | 2020 | Details |
| A06592 | 32815965 | Food Funct | A multi-targeting strategy to ameliorate high-fat-diet- and fructose-induced (western diet-induced) non-alcoholic fatty liver disease (NAFLD) with supplementation of a mixture of legume ethanol extracts. | 2020 | Details |
| A06596 | 32813194 | Hepatol Int | Benefits of prolonged-release pirfenidone plus standard of care treatment in patients with advanced liver fibrosis: PROMETEO study. | 2020 | Details |
| A06612 | 32808824 | Can J Physiol Pharmacol | Intricacies of the endothelin system in human obesity: role in the development of complications and potential as a therapeutic target. | 2020 | Details |
| A06618 | 32805401 | Free Radic Biol Med | Cyanidin-3-O-β-glucoside inactivates NLRP3 inflammasome and alleviates alcoholic steatohepatitis via SirT1/NF-κB signaling pathway. | 2020 | Details |
| A06619 | 32805210 | Chem Biol Interact | High fat diet-triggered non-alcoholic fatty liver disease: A review of proposed mechanisms. | 2020 | Details |
| A06624 | 32803141 | Cardiovasc Endocrinol Metab | Nonalcoholic fatty liver disease: implications for endocrinologists and cardiologists. | 2020 | Details |
| A06625 | 32802885 | Biomed Res Int | Protective Effects of MitoTEMPO on Nonalcoholic Fatty Liver Disease via Regulating Myeloid-Derived Suppressor Cells and Inflammation in Mice. | 2020 | Details |
| A06628 | 32801031 | J Nutr Biochem | Anti-inflammatory activities of green tea catechins along the gut-liver axis in nonalcoholic fatty liver disease: lessons learned from preclinical and human studies. | 2020 | Details |
| A06638 | 32798334 | Immun Inflamm Dis | Cannabinoid receptor type 1 antagonist inhibits progression of obesity-associated nonalcoholic steatohepatitis in a mouse model by remodulating immune system disturbances. | 2020 | Details |
| A06639 | 32798261 | Phytother Res | The effect of saffron supplementation on some inflammatory and oxidative markers, leptin, adiponectin, and body composition in patients with nonalcoholic fatty liver disease: A double-blind randomized clinical trial. | 2020 | Details |
| A06643 | 32796650 | Metabolites | Metabolic Profiling Reveals Aggravated Non-Alcoholic Steatohepatitis in High-Fat High-Cholesterol Diet-Fed Apolipoprotein E-Deficient Mice Lacking Ron Receptor Signaling. | 2020 | Details |
| A06649 | 32795119 | Metab Syndr Relat Disord | Omeprazole and Spirulina Platensis Ameliorate Steatohepatitis in Experimental Nonalcoholic Fatty Liver Disease. | 2020 | Details |
| A06665 | 32789148 | Clin Nutr Res | Association between Inflammatory Biomarkers and Nutritional Status in Fatty Liver. | 2020 | Details |
| A06688 | 32780531 | Mol Nutr Food Res | Lactobacillus rhamnosus GG and Oat Beta-Glucan Regulated Fatty Acid Profiles along the Gut-Liver-Brain Axis of Mice Fed with High Fat Diet and Demonstrated Antioxidant and Anti-Inflammatory Potentials. | 2020 | Details |
| A06689 | 32780094 | Inflamm Bowel Dis | Prevalence of Nonalcoholic Fatty Liver Disease in Patients With Inflammatory Bowel Disease: A Systematic Review and Meta-analysis. | 2021 | Details |
| A06690 | 32779505 | J Am Heart Assoc | Effects of Epeleuton, a Novel Synthetic Second-Generation n-3 Fatty Acid, on Non-Alcoholic Fatty Liver Disease, Triglycerides, Glycemic Control, and Cardiometabolic and Inflammatory Markers. | 2020 | Details |
| A06692 | 32779242 | Hepatology | 17-Beta Hydroxysteroid Dehydrogenase 13 Deficiency Does Not Protect Mice From Obesogenic Diet Injury. | 2021 | Details |
| A06708 | 32774420 | Evid Based Complement Alternat Med | Anti-inflammatory Mechanism of Ruzu Bitters on Diet-Induced Nonalcoholic Fatty Liver Disease in Male Wistar Rats. | 2020 | Details |
| A06712 | 32773025 | Biol Aujourdhui | [Cell death mechanisms in non-alcoholic steatohepatitis]. | 2020 | Details |
| A06713 | 32772909 | Comb Chem High Throughput Screen | Evaluation of Insulin Resistance Induced Brain Tissue Dysfunction in Obese Dams and their Neonates: Role of Ipriflavone Amelioration. | 2021 | Details |
| A06740 | 32764281 | Nutrients | The Relationship between Choline Bioavailability from Diet, Intestinal Microbiota Composition, and Its Modulation of Human Diseases. | 2020 | Details |
| A06741 | 32763355 | Toxicol Appl Pharmacol | Hesperetin protects against palmitate-induced cellular toxicity via induction of GRP78 in hepatocytes. | 2020 | Details |
| A06742 | 32763266 | J Hepatol | Hepatocyte pyroptosis and release of inflammasome particles induce stellate cell activation and liver fibrosis. | 2020 | Details |
| A06745 | 32762830 | J Pharm Pharm Sci | Cannabis and the Gastrointestinal Tract. | 2020 | Details |